statistiche ricercatore

Continente	#
NA - Nord America	621
AS - Asia	350
EU - Europa	350
SA - Sud America	100
Continente sconosciuto - Info sul continente non disponibili	44
AF - Africa	15
OC - Oceania	2
Totale	1.482

Nazione	#
US - Stati Uniti d'America	584
IT - Italia	176
SG - Singapore	121
BR - Brasile	81
CN - Cina	76
HK - Hong Kong	44
RU - Federazione Russa	40
DE - Germania	25
GB - Regno Unito	25
VN - Vietnam	24
IN - India	20
CA - Canada	18
FR - Francia	18
SE - Svezia	17
FI - Finlandia	12
BD - Bangladesh	11
IL - Israele	9
JP - Giappone	9
AR - Argentina	7
ID - Indonesia	7
PL - Polonia	6
HU - Ungheria	5
AT - Austria	4
CR - Costa Rica	4
EC - Ecuador	4
MX - Messico	4
NL - Olanda	4
UZ - Uzbekistan	4
ZA - Sudafrica	4
AE - Emirati Arabi Uniti	3
CI - Costa d'Avorio	3
CZ - Repubblica Ceca	3
ES - Italia	3
GT - Guatemala	3
JM - Giamaica	3
NO - Norvegia	3
PK - Pakistan	3
AU - Australia	2
AZ - Azerbaigian	2
BE - Belgio	2
CO - Colombia	2
CW - ???statistics.table.value.countryCode.CW???	2
IQ - Iraq	2
IR - Iran	2
KR - Corea	2
LT - Lituania	2
MD - Moldavia	2
PH - Filippine	2
PR - Porto Rico	2
SA - Arabia Saudita	2
SN - Senegal	2
TR - Turchia	2
UY - Uruguay	2
BB - Barbados	1
CL - Cile	1
DZ - Algeria	1
EE - Estonia	1
EG - Egitto	1
IE - Irlanda	1
KE - Kenya	1
KZ - Kazakistan	1
LB - Libano	1
MA - Marocco	1
ML - Mali	1
MY - Malesia	1
NI - Nicaragua	1
NP - Nepal	1
PA - Panama	1
PY - Paraguay	1
SC - Seychelles	1
SI - Slovenia	1
SR - Suriname	1
TH - Thailandia	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.441

Nome	#
Harmaline-based scaffold as Human Caseinolytic Protease P (hClpP) inducers for Diffuse Intrinsic Pontine Glioma (DIPG) treatment	186
A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior	159
Cyclooxygenase-1 Inhibition: A Promising Theragnostic Approach for Ovarian Cancer	148
Molecular simplification of natural products: Synthesis, antibacterial activity, and molecular docking studies of berberine open models	148
Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery	129
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes	120
Repurposing of natural origin compounds as HsClpP inducers to treat diffuse midline glioma (DMG)	113
COX-1 INHIBITORS AS ANTI-PLATELET AGENTS IN COVID-19	111
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment	107
CHALLENGE TRANSABILITY OF “IN VITRO” TO “IN VIVO”: GENE-EXPRESSION BIOMARKERS AND FLUORESCENT IMAGE-GUIDED SURGERY PROBES IDENTIFICATION FOR OVARIAN CANCER	106
DIPG-27. Diffuse Intrinsic Pontine Glioma (DIPG) challenge: from gene expression profile to drug.	100
Therapeutic Role of Cyclooxygenase-1 (COX-1) Inhibition, Challenging the Conventional View of COX-1 as Purely Constitutive	55
Totale	1.482

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	5	0	0	0	0	0	1	0	0	1	1	1	1
2022/2023	31	2	3	1	1	4	3	1	9	6	1	0	0
2023/2024	140	1	4	5	7	5	5	1	1	82	16	1	12
2024/2025	313	16	6	9	12	21	19	57	36	23	29	27	58
2025/2026	707	88	31	41	75	71	39	74	29	86	80	46	47
2026/2027	279	47	23	101	102	6	0	0	0	0	0	0	0
Totale													1.482